722: Randomized phase III trial of active specific immunotherapy (ASI) versus control in patients with Duke's B2, B3 or C colon cancer
- 30 September 1997
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 33, S162
- https://doi.org/10.1016/s0959-8049(97)85330-0
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: